↓ Skip to main content

PLOS

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)

Overview of attention for article published in PLOS ONE, August 2011
Altmetric Badge

Mentioned by

news
6 news outlets
policy
1 policy source
patent
3 patents

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
123 Mendeley
Title
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
Published in
PLOS ONE, August 2011
DOI 10.1371/journal.pone.0021225
Pubmed ID
Authors

Gavin J. Churchyard, Cecilia Morgan, Elizabeth Adams, John Hural, Barney S. Graham, Zoe Moodie, Doug Grove, Glenda Gray, Linda-Gail Bekker, M. Juliana McElrath, Georgia D. Tomaras, Paul Goepfert, Spyros Kalams, Lindsey R. Baden, Michelle Lally, Raphael Dolin, William Blattner, Artur Kalichman, J. Peter Figueroa, Jean Pape, Mauro Schechter, Olivier Defawe, Stephen C. De Rosa, David C. Montefiori, Gary J. Nabel, Lawrence Corey, Michael C. Keefer, and the NIAID HIV Vaccine Trials Network

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
South Africa 1 <1%
Unknown 121 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 18%
Researcher 22 18%
Student > Master 22 18%
Student > Bachelor 11 9%
Student > Doctoral Student 9 7%
Other 16 13%
Unknown 21 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 20%
Medicine and Dentistry 21 17%
Biochemistry, Genetics and Molecular Biology 19 15%
Immunology and Microbiology 11 9%
Social Sciences 5 4%
Other 17 14%
Unknown 26 21%